Inspire Medical Systems (INSP) reported fourth-quarter 2025 revenue of $269.1 million, up 12.25% year‑over‑year and just under the consensus revenue estimate of $271.0 million.
Key profitability highlights:
Cash flow and balance sheet items:
Additional note: cost of sales was $36.1 million, and shares of INSP were down 9.1% since market close.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Inspire Medical Systems Inc. Insider Trading Activity
Inspire Medical Systems Inc. insiders have traded $INSP stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:
- RICHARD BUCHHOLZ (Chief Financial Officer) sold 11,000 shares for an estimated $1,027,290
- SHAWN MCCORMICK has made 0 purchases and 2 sales selling 3,200 shares for an estimated $421,760.
- JOHN RONDONI (See Remarks) sold 109 shares for an estimated $10,900
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Inspire Medical Systems Inc. Hedge Fund Activity
We have seen 193 institutional investors add shares of Inspire Medical Systems Inc. stock to their portfolio, and 226 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRAGONEER INVESTMENT GROUP, LLC removed 2,354,411 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $174,697,296
- CITADEL ADVISORS LLC added 1,739,734 shares (+20054.6%) to their portfolio in Q3 2025, for an estimated $129,088,262
- FMR LLC removed 1,536,430 shares (-67.2%) from their portfolio in Q3 2025, for an estimated $114,003,106
- WASATCH ADVISORS LP removed 1,498,481 shares (-91.7%) from their portfolio in Q3 2025, for an estimated $111,187,290
- BAILLIE GIFFORD & CO removed 1,084,350 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $100,009,600
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,058,890 shares (+174.1%) to their portfolio in Q3 2025, for an estimated $78,569,638
- M&T BANK CORP added 931,049 shares (+inf%) to their portfolio in Q4 2025, for an estimated $85,870,649
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Inspire Medical Systems Inc. Government Contracts
We have seen $3,857,842 of award payments to $INSP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $142,010
- PROSTHETIC ORDER - IMPLANT ITEMS: $75,226
- IMPLANT: $50,150
- SURGICAL IMPLANT: $50,150
- IMPLANTABLE PULSE GENERATOR: $50,150
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Inspire Medical Systems Inc. Analyst Ratings
Wall Street analysts have issued reports on $INSP in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 01/08/2026
- RBC Capital issued a "Outperform" rating on 12/17/2025
- Mizuho issued a "Outperform" rating on 12/17/2025
- Baird issued a "Outperform" rating on 12/04/2025
- Wolfe Research issued a "Outperform" rating on 11/25/2025
- Stifel issued a "Buy" rating on 11/24/2025
- Piper Sandler issued a "Overweight" rating on 11/04/2025
To track analyst ratings and price targets for Inspire Medical Systems Inc., check out Quiver Quantitative's $INSP forecast page.
Inspire Medical Systems Inc. Price Targets
Multiple analysts have issued price targets for $INSP recently. We have seen 14 analysts offer price targets for $INSP in the last 6 months, with a median target of $127.5.
Here are some recent targets:
- Shagun Singh from RBC Capital set a target price of $90.0 on 01/27/2026
- Larry Biegelsen from Wells Fargo set a target price of $145.0 on 01/14/2026
- Richard Newitter from Truist Securities set a target price of $120.0 on 01/08/2026
- Danielle Antalffy from UBS set a target price of $91.0 on 12/23/2025
- Anthony Petrone from Mizuho set a target price of $130.0 on 12/17/2025
- Robbie Marcus from JP Morgan set a target price of $118.0 on 12/16/2025
- Suraj Kalia from Oppenheimer set a target price of $175.0 on 12/08/2025
